BEIJING BIOSTAR PHARMACEUTICALS CO., LTD. - B - H SHARES (2563)

BIOSTAR PHARM-B (2563)

HK$4.410

0.000 (0.00%)

Prev. Close is the most recent non-zero closing value or settlement price.PREV. CLOSE
HK$4.410

Open price is the first traded price of the day. The opening price is reported after 09:20:00 HKT.OPEN
-

TURNOVER
-

VOLUME
-

MKT CAP
HK$955.73M

LOT SIZE
200

BID
-

ASK
-

EPS
-

P/E
-

DIV YIELD
-

	INTRA-DAY	52W
High	-	HK$39.500
Low	-	HK$4.280

Information is available after the market opens and is delayed by at least 15 minutes.

Updated: 31 Mar 2025

Stock Quote Lookup

Export to Excel

1min

5min

15min

Hourly

Prev. Close
4.410

All charts use the last traded price or closing price.

View All on HKEXnews

COMPANY ANNOUNCEMENTS

COMPANY PROFILE

Beijing Biostar Pharmaceuticals Co Ltd is a Chinea-based company principally engaged in the research, development, production and sales of innovative drugs. The Company's products and pipeline mainly include Utidelone Injection, Utidelone Capsule, Utidelone Nanoformulation, Utidelone Antibody Drug Conjugate (ADC), BG22, BG18 and BG44. The Company's products are principally used for the treatment of relapsed or metastatic breast cancer, neoadjuvant treatment of human epidermal growth factor receptor 2 (HER2)-breast cancer neoadjuvant, advanced non-small cell lung cancer (NSCLC), solid tumors, breast cancer brain metastasis, lung cancer brain metastasis and other brain tumor indications. The Company mainly conducts its businesses in the domestic market. *

216,720,857 (as at 30 Apr 2025)

Industry Healthcare - Pharmaceuticals & Biotechnology - Biotechnology

Listing Date 31 Oct 2024

Financial Year Ends -

Chairman Tang Li

Principal Office 1202, Tower B
Yicheng Fortune Center
Beijing Economic-Technological
Development Area, Beijing, PRC

Place of Incorporation PRC

Listing Category Primary Listing

Registrar Computershare Hong Kong Investor Services Ltd.

Disclaimer

The industry and sector classification results of the Hang Seng Industry Classification System referred to in this section (“HSICS Information”) is provided by Hang Seng Indexes Company Limited. Neither Hang Seng Indexes Company Limited nor any of its holding companies and subsidiaries nor HKEX Information Services Limited nor any of its holding companies and subsidiaries provides any warranties of any kind in relation to such HSICS Information (including, without limitation, that the HSICS Information is fit or suitable for any purpose, or that any person will obtain any particular results by using or relying on the HSICS Information) or accepts any responsibilities for its accuracy, completeness, timeliness and/or consistency, or for any loss or damage whatsoever and howsoever suffered or incurred by any person. With the use of or the access to the HSICS Information any person receiving any HSICS Information from HKEX Information Services Limited or any of its holding companies or subsidiaries irrevocably and unconditionally accepts and agrees to be bound by this disclaimer.

Important Notes - dissemination of HSICS Information

Please contact Hang Seng Indexes Company Limited and enter into a licence agreement with it before you further disseminate any of the industry and sector classification results of the Hang Seng Industry Classification System to any other person.

Notes on Number of Issued Shares / Issued Units

1. Listed issuers are required by Listing Rules to publish a Monthly Return to provide an update on a fixed monthly basis the movement of its issued capital by 8:30am of the fifth business day following the end of each calendar month. Listed issuers are also required to publish a Next Day Disclosure Return in respect of changes in issued share capital, in some cases by 8:30am of the next business day and in other cases subject to a 5% de minimis threshold and certain other criteria (e.g. aggregation). Please refer to the Listing Rules (MAIN / GEM) for details.

2. Please visit the HKEXnews website to retrieve the latest Monthly Returns and Next Day Disclosure Returns for the most up-to-date number of issued shares / issued units disclosed by the listed issuers.

3. In most cases, the number of issued shares / issued units presented here should be consistent with the latest figure disclosed by the listed issuers. Discrepancies could however arise due to one or more of the following reasons:

a. Updating time-lag

The number of issued shares / issued units presented is generally updated within 7 days after the Monthly Returns and Next Day Disclosure Returns published by the listed issuers on the HKEXnews website. Hence, the information presented here may not be the most up-to-date information submitted by the listed issuers as required under the Listing Rules.

b. Rights issues or bonus issues

The number of issued shares / issued units presented here will be adjusted with effect from the ex-date in the event of announced rights issues or announced bonus issues. In this case, both the number of issued shares / issued units before and after the adjustment will be presented.

c. Share splits or share consolidations

The number of issued shares / issued units presented here will be adjusted on the effective date in the event of share splits or share consolidations.

d. Conversion of convertible notes into shares

If the change of the number of issued shares / issued units is due to conversion of convertible bonds, the number of issued shares / issued units presented here may be updated based on the related company announcement.

4. For H-share companies, the number of issued shares refers to "H-shares" only.

5. For Depositary Receipts, the number of issued shares refers to the number of Hong Kong Depositary Receipts approved for listing only.

6. The compilation of market capitalisation by the Exchange is based on the number of issued shares updated as above.

7. For dual counter stocks, the number of issued shares is the aggregated total of both HKD and RMB shares.

8. For Stapled Securities, the number of issued shares (including the ordinary shares and preference shares) (or issued units) refers to the number of Stapled Securities (or number of units) approved for listing only.

Updated: 01 Jun 2025 08:03 HKT

* Company profile is provided by Refinitiv.

ENTITLEMENT

Date Announced	Ex-Date	Details	Financial Year End	Book Close Date	Payment date may be indicative only.Payment Date

Updated:

Dividend details are sourced from Announcement Forms published on HKEXnews

See All

RELATED PRODUCTS

Code	Call / Put	Expiry	Strike	Last Price
No related products

Updated: